What You Should Know:
– DeepScribe, the ambient AI of choice for specialty care, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, today announced a partnership that brings DeepScribe’s AI documentation to clinicians using Flatiron’s OncoEMR®, a leading cloud based electronic medical record platform.
– The partnership establishes DeepScribe as the first ambient AI solution partner for Flatiron Health.
Transforming Oncology Documentation: DeepScribe and Flatiron Partner to Enhance Cancer Care Efficiency
DeepScribe, a leader in ambient AI technology since its founding in 2017, enables clinicians to maximize every patient encounter by transforming conversations into accurate, complete documentation and actionable insights. Its AI platform is tailored to the unique requirements of various specialties, including complex medical fields like oncology, to improve note accuracy, operational efficiency, and clinician satisfaction.
In a groundbreaking collaboration, DeepScribe has partnered with Flatiron Health to integrate its oncology-specific AI capabilities with OncoEMR. This integration empowers over 4,200 providers across more than 800 community-based cancer care locations in the U.S. to significantly reduce charting time while fostering stronger connections with their patients. Key benefits of this partnership include:
- Ease of Use: 91% of oncologists reported the platform as intuitive and user-friendly.
- High Adoption Rates: Over 80% of large oncology groups have adopted DeepScribe’s AI-driven technology.
- Daily Utilization: Nearly 1,000 oncologists rely on DeepScribe for care documentation each day.
DeepScribe’s oncology-optimized AI enhances workflow efficiency by automatically generating structured clinical notes. These notes incorporate critical contextual details, such as interval history from previous visits, and intelligently organize treatment plans with relevant ICD-10 codes. The AI-generated notes are seamlessly integrated into OncoEMR, populating patient charts for clinician review and approval. This streamlined process ensures:
- Reduced Documentation Burden: Clinicians save time by focusing on patient care rather than administrative tasks.
- Accurate and Contextual Notes: The system captures intricate cancer care details and organizes them efficiently.
According to DeepScribe CEO and Co-founder Matthew Ko, “This partnership enables Flatiron clinicians to maximize patient interactions, equipped with the time and information they need to provide personalized care. The seamless integration with OncoEMR ensures that our shared vision for meaningful cancer care is realized.”
This collaboration solidifies DeepScribe’s position as a trusted ambient AI solution for oncology, making it a cornerstone technology for advancing cancer care documentation across the Flatiron network.
